Health1 month ago
Arcus Biosciences Launches $250 Million Public Offering
Arcus Biosciences, a clinical-stage global biopharmaceutical company, has successfully priced its underwritten public offering at $250 million. The offering includes 13.7 million shares priced at $18.25...
